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        Diabetes is a leading cause of blindness, end-stage 
renal failure, and peripheral neuropathy in most 
developed countries. Hyperglycemia-induced 
reactive oxygen species (ROS) initiate the com-
plex series of molecular events that result in dia-
betic tissue damage, and transgenic expression of 
superoxide dismutase prevents diabetic compli-
cations in animal models (  1  ). Consistent with 
this, multiple variations in SOD1 are signifi  cantly 
associated with persistent microalbuminuria and 
severe nephropathy in patients with Type 1 dia-
betes from the DCCT/EDIC (Diabetes Control 
and Complications Trial/Epidemiology of Dia-
betes Interventions and Complications) study 
(  2  ). Diabetes is also a major independent risk fac-
tor for atherosclerotic cardiovascular disease 
(CVD). Patients with type 2 and type 1 diabetes 
both have a two- to fourfold higher risk of CVD 
compared with those without diabetes (  3  –  5  ), and 
subjects with impaired glucose tolerance have a 
CVD risk almost as high as that seen in patients 
with type 2 diabetes (  6  ). 
  In the DCCT/EDIC study, reduction of 
time-averaged mean levels of glycemia, measured 
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  The current goal of diabetes therapy is to reduce time-averaged mean levels of glycemia, 
measured as HbA1c, to prevent diabetic complications. However, HbA1c only explains 
  <  25% of the variation in risk of developing complications. Because HbA1c does not corre-
late with glycemic variability when adjusted for mean blood glucose, we hypothesized that 
transient spikes of hyperglycemia may be an HbA1c  –  independent risk factor for diabetic 
complications. We show that transient hyperglycemia induces long-lasting activating 
epigenetic changes in the promoter of the nuclear factor     B (NF-    B) subunit p65 in aortic 
endothelial cells both in vitro and in nondiabetic mice, which cause increased p65 gene 
expression. Both the epigenetic changes and the gene expression changes persist for at 
least 6 d of subsequent normal glycemia, as do NF-    B  –  induced increases in monocyte 
chemoattractant protein 1 and vascular cell adhesion molecule 1 expression. Hyperglyce-
mia-induced epigenetic changes and increased p65 expression are prevented by reducing 
mitochondrial superoxide production or superoxide-induced     -oxoaldehydes. These results 
highlight the dramatic and long-lasting effects that short-term hyperglycemic spikes can 
have on vascular cells and suggest that transient spikes of hyperglycemia may be an 
HbA1c  –  independent risk factor for diabetic complications. 
© 2008 El-Osta et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi  rst six months 
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inducing specifi  c activating methylation of histones associ-
ated with the p65 promoter. Histone methylation is an im-
portant posttranslational modifi  cation involved in fundamental 
processes such as transcriptional regulation and genome sta-
bility (  13, 14  ). In particular, methylation of H3K4 (lysine 4 of 
histone 3) favors transcriptional activation (  15  ). In mamma-
lian cells, H3K4 methylation is mediated by several histone 
methyltransferases (HMTs). The mammalian HMT Set7 has 
been shown to monomethylate histone H3K4 (  16  ). In con-
trast, SET1a, SET1b, and four MLL-family HMTs function 
as tri- and dimethyltransferases (  17  ). 
  To determine whether Set7 is mobilized by HG to main-
tain the active transcriptional state, chromatin immunoprecipi-
tations (ChIPs) were performed with antibody to Set7, and 
association with the proximal p65 promoter was determined 
by quantitative real time PCR (  Fig. 1, c and d  ; and Fig. S1 c) (  18  ). 
as HbA1c, decreased the risk of sustained retinopathy progres-
sion, the primary DCCT outcome, by 73%. However, for the 
entire study group, HbA1c only explained   <  25% of the varia-
tion in risk of developing this complication (  7  ). Because 
chronic hyperglycemia has been shown to cause increased 
acetylation of various histone lysine residues, a general epigen-
etic marker associated with increased gene transcription (  8  ), we 
hypothesized that transient exposure to hyperglycemia would 
cause persistent increases in proatherogenic gene expression 
during subsequent periods of normal glycemia because of spe-
cifi  c long-lasting epigenetic changes induced by ROS and its 
consequences. These transient spikes of hyperglycemia could 
be an HbA1c  –  independent risk factor for diabetic complica-
tions. The p65 subunit of the pleiotropic transcription factor 
NF    B was selected for study because NF-    B  –  driven proin-
fl  ammatory gene expression appears to play a major role in the 
pathogenesis of atherosclerosis (  9, 10  ), and p65 expression is 
signifi  cantly increased in aorta of diabetic ApoE-null mice and 
in circulating mononuclear cells of diabetic patients (  11, 12  ). 
    RESULTS   
  Transient hyperglycemia promotes p65 gene transcription 
and NF-    B activation 
  To create a model of transient hyperglycemia, we fi  rst incubated 
either primary bovine aortic endothelial cells (BAECs) or pri-
mary human aortic endothelial cells (HAECs) in high glucose 
(HG) for 16 h and then returned the media glucose concentra-
tion to physiological glucose levels for 6 d (  Fig. 1 a  ).   Transcrip-
tion of p65 was increased by transient exposure to HG in both 
HAECs and BAECs (  Fig. 1 a   and Fig. S1 a, available at http://
www.jem.org/cgi/content/full/jem.20081188/DC1). In con-
trast, transient hyperglycemia did not increase expression of the 
NF-    B subunits RElB, c-Rel, p50/p105, or p52/p100 (un-
published data). Remarkably, this increase in p65 transcription 
persisted during subsequent incubation at physiological glucose 
levels for the entire 6-d experimental period (  Fig. 1 b   and Fig. 
S1 a). Expression of p65 increased with glucose concentration 
from 5 to 30 mM (Fig. S1 b). Protein levels of p65 and NF-    B 
p65 activity were also increased by transient exposure to HG, 
and these also persisted for 6 d (Fig. S2). Addition of actinomy-
cin D to the physiological glucose media after 16 h of HG re-
duced the elevated p65 expression to normal levels at 2 d, which 
is consistent with a primary role for transcription (unpublished 
data). To exclude the possibility that increased p65 expression 
occurs as a result of osmotic stress, vascular endothelial cells 
were incubated in 30 mM mannitol. In these cells, there was 
no change in p65 expression (unpublished data). Association of 
RNA polymerase II with the p65 promoter was also increased 
by transient exposure to HG, and this also persisted for 6 d (Fig. 
S3), confi  rming that p65 transcription was indeed increased. 
  Transient hyperglycemia induces persistent mobilization 
of Set7 to the p65 promoter 
  Based on this observation, we postulated that transient expo-
sure to HG induces persistent activation of p65 expression by 
    Figure 1.         Persistent increase in Set7-mediated histone methyla-
tion and p65 gene expression caused by transient hyperglycemia.  
(a) Schematic representation of experimental model. (b) NF-    B p65 sub-
unit mRNA levels in response to transient hyperglycemia in HAECs. 
(c) Schematic representation of the human NF-    B p65 proximal promoter 
region. (d) ChIP of NF-    B p65 promoter by Set7 and H3K4me1 after tran-
sient hyperglycemia in HAECs. (e) H3K4me1 associated with the p65 pro-
moter after transient hyperglycemia in WT and SET7 knockdown cells. 
(f) p65 expression after transient hyperglycemia in WT HAECs and SET7 
knockdown cells. (g) Effect of p65 and SET7 knockdown on MCP-1 and 
VCAM-1 expression after transient hyperglycemia. *, P   <   0.05 versus LG; 
  ¶  , P   <   0.05 versus WT group. For B and D  –  F,   n   = 3. Error bars show SEM.     JEM VOL. 205, September 29, 2008 
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in cells incubated in HG (Fig. S4 c). However, this increase in 
H3 acetylation was not associated with the Set7 recruitment 
and increased H3K4me1, which are both induced by incuba-
tion in HG (Fig. S4 d). Similarly, this increase in acetylation 
was also not associated with the increased expression of p65, 
MCP-1, or VCAM-1 induced by incubation in HG (Fig. S4 e). 
Together, these data indicate that increased histone acetylation 
is not suffi   cient to induce the eff  ects observed after exposure 
to HG. 
  Set7 knockdown prevents glucose-induced up-regulation of 
p65 and the NF-    B  –  dependent genes MCP-1 and VCAM-1 
  Having demonstrated that Set7 and H3K4me1 are associated 
with p65 promoter, we next wished to investigate the eff  ect 
of loss of Set7 on p65-mediated transcription in HAECs using 
Chromatin from both HAECs and BAECs exposed to tran-
sient hyperglycemia (16 h) was signifi  cantly enriched for Set7 
on the p65 promoter when compared with antibody controls. 
Remarkably, the increased Set7 association with the p65 pro-
moter, like the increased expression of NF-    B, persisted in a 
normoglycemic environment for the entire 6-d experimental 
period (P   <   0.05). To exclude the possibility that recruitment 
of Set7 occurs as a result of osmotic stress, vascular endothelial 
cells were incubated in 30 mM mannitol. In these cells, there 
was no change in Set7 enzyme binding on the p65 promoter 
(unpublished data). To confi  rm that recruitment of Set7 did 
indeed result in increased H3K4 methylation, we analyzed 
methylation of histone H3K4. ChIP analysis indicated that 
there was a specifi  c and persistent increase in histone H3K4 
monomethylation on p65 chromatin compared with no anti-
body control (  Fig. 1 c   and Fig. S1 c). 
  Transient hyperglycemia increases a specifi  c epigenetic 
mark, histone 3 lysine 4 monomethylation (H3K4me1), 
in the proximal promoter region of the p65 gene 
  Although neither di- nor trimethyl H3K4 was aff  ected by 
transient hyperglycemia in the single amplicon we examined 
(unpublished data), these marks are frequently found down-
stream of transcription start sites (TSS) (  19  ). We therefore per-
formed ChIP walking for H3K4me1, H3K4 dimethylation 
(H3K4me2), and H3K4 trimethylation 4 (H3K4me3) from nt 
1 to +1500 of the p65 gene, as well as from nt     1 to     450 of 
the p65 promoter in HAECs (  Fig. 2 a  ).   The only statistically 
signifi  cant change occurred with H3K4me1 in the proximal 
promoter near the TSS (  Fig. 2 b  ). This 2.5-fold increase was 
present after 16 h of HG and remained at this level after 6 d of 
subsequent exposure to low glucose (LG). Neither the small 
increases of H3K4me1 at +450 and +750 nor the slight in-
crease of H3K4me2 and H3K4me3 near the TSS were signifi  -
cantly diff  erent from LG (  Fig. 2, c and d  ). To show that our 
optimized ChIP assays are specifi  c for the indicated epitopes, 
we performed ChIPs using an antibody that recognizes un-
modifi  ed histone 3 (unpublished data). Association of the tri-
methyl H3K4 binding partner NURF with the p65 promoter 
was also not increased by transient exposure to HG (unpub-
lished data). Consistent with these data, neither MLL1 nor 
hSET1 association with the p65 promoter was changed at any 
time point (unpublished data). Because hyperacetylation of 
histones by p300 and other histone acetyl transferases has been 
associated with recruitment of chromatin remodeling proteins, 
we also examined levels of pan-acetylated H3, acetyl H3K9, 
and acetyl H3K14 associated with the p65 promoter. Transient 
hyperglycemia increased all three, and this increase also per-
sisted during subsequent incubation at physiological glucose 
levels for 6 d (Fig. S4, a and b, respectively, available at http://
www.jem.org/cgi/content/full/jem.20081188/DC1). To de-
termine whether this increased histone acetylation is suffi   cient 
to induce the observed eff  ects of HG, we used the histone 
deacetylase inhibitor trichostatin A (TSA). TSA treatment of 
cells incubated in LG increased levels of pan-acetylated H3, 
H3K9, and H3K14 acetylation to acetylation levels observed 
    Figure 2.         Partial quantitative PCR  –  based chromosomal walking of 
the p65 gene by ChIP.   (a) Schematic representation of the p65 proximal 
promoter and downstream sequence mapped. (b) Profi  les of H3K4me1 
after 16-h exposure to LG, 16-h exposure to HG, and 16-h exposure to 
HG followed by 6 d of LG. (c) Profi  les of H3K4me2 after 16-h exposure to 
LG, 16-h exposure to HG and 16-h exposure to HG followed by 6 d of LG. 
(d) Profi  les of H3K4me3 after 16-h exposure to LG, 16-h exposure to HG, 
and 16-h exposure to HG followed by 6 d of LG. *, P   <   0.05 versus LG for 
HG group; #, P   <   0.05 versus LG for HG (16 h) + LG (6 d) group. For B  –  D, 
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signifi  cant covalent modifi  cations of intracellular proteins 
(  24  ). Overexpression of UCP-1, MnSOD, or GLO1 also 
prevented the increased association of Set7 and H3K4me1 
with the p65 promoter in response to transient hyperglyce-
mia alone (  Fig. 3 b  ). 
  Transcriptional competence is typically associated with 
changes in chromatin structure. Therefore, we next exam-
ined the eff  ect of transient hyperglycemia on remodeling of 
the p65 locus (  Fig. 3 c  ). HAECs were infected with UCP-1, 
MnSOD, or GLO1 adenovirus and then treated as described 
previously. Nuclear extracts were digested with the restric-
tion endonuclease Eag1 (  Fig. 1 c  ), and a 161-bp fragment of 
the p65 promoter was quantifi  ed by quantitative PCR ampli-
fi  cation. Transient hyperglycemia caused active remodeling 
of the p65 promoter, proximal to the TSS, with an increased 
susceptibility to Eag1 digestion indicating transition to an 
open chromatin conformation (  Fig. 3 c  ). This remodeling of 
the p65 promoter also persisted for 6 d of normoglycemia 
lentivirus shRNA. As shown in   Fig. 1 e  , in Set7 knockdown 
HAECs (SET7 shRNA), transient hyperglycemia failed to in-
duce increased H3K4 monomethylation. Similarly, knock-
down of Set7 prevented the increase and persistence of NF-   B 
p65 expression induced by transient hyperglycemia (  Fig. 1 f  ). 
Finally, we examined the eff  ects of transient hyperglycemia 
on the expression of two NF-    B p65-activated genes relevant 
to hyperglycemia-induced arterial pathology, monocyte che-
moattractant protein 1 (MCP-1), and vascular cell adhesion 
molecule 1 (VCAM-1). MCP-1 is a chemokine involved in 
the recruitment of plasma monocytes in the early stages of 
atherosclerosis, and VCAM-1 promotes monocyte adhesion 
to arterial endothelial cells (  20  ). Expression of both MCP-1 
and VCAM-1 was increased by transient hyperglycemia (  Fig. 
1 g  ) and remained elevated during 6 d of subsequent incuba-
tion at physiological glucose levels. Expression of three other 
NF-    B p65-dependent proinfl  ammatory genes, the cytokine 
IL-6, inducible NOS2 (nitric oxide synthase), and the proin-
fl  ammatory adhesion molecule ICAM1, also increased after 
exposure to transient HG and this increase persisted for 6 d of 
subsequent exposure to 5 mM glucose (unpublished data). 
  To link this increased expression to the changes in p65 
expression and activity, we measured the eff  ect of p65 knock-
down on hyperglycemia-induced MCP-1 and VCAM-1 ex-
pression. Similarly, to link this increased expression of MCP-1 
and VCAM-1 to Set7, we also determined the eff  ect of SET7 
knockdown on hyperglycemia-induced MCP-1 and VCAM-1 
expression. Both knockdown of p65 and SET7 prevented the 
increase in MCP-1 and VCAM-1 expression induced by 
transient hyperglycemia (  Fig. 1 g  ). 
  Mitochondrial ROS and GLO-1 substrate participate 
in glucose-induced changes in p65 gene expression 
and in remodeling of the p65 promoter 
  Because mitochondrial overproduction of superoxide has 
been shown to initiate a large number of hyperglycemia-in-
duced mechanisms related to the pathogenesis of diabetic 
complications (  21, 22  ), we next investigated the eff  ect of 
inhibiting mitochondrial superoxide production on p65 ex-
pression. As shown in   Fig. 3 a  , the increase in p65 expression 
induced by transient hyperglycemia was completely pre-
vented by overexpression of either uncoupling protein-1 
(UCP-1) or manganese superoxide dismutase (MnSOD), 
both of which prevent hyperglycemia-induced superoxide 
accumulation (  21, 22  ).   Transient hyperglycemia had no ef-
fect on endogenous MnSOD expression (unpublished data), 
a fi  nding which is consistent with our observation that the 
NF-    B subunit c-Rel was not induced by transient hyper-
glycemia (  23  ). In addition, we found that overexpression 
of the     -oxoaldehyde degradation enzyme glyoxalase 1 
(GLO1) also prevented the increase in p65 expression in-
duced by transient hyperglycemia (  Fig. 3 a  ). The major 
physiological substrate for GLO1, methylglyoxal, is a highly 
reactive dicarbonyl that accumulates in several cell types ex-
posed to hyperglycemia as a consequence of increased mito-
chondrial superoxide production. This results in functionally 
    Figure 3.         UCP1, MnSOD, and GLO1 prevent persistent increases in 
Set7-mediated histone methylation and p65 gene expression.  
(a) p65 mRNA after transient hyperglycemia, measured by quantitative 
PCR. (b) ChIP analyses for association of Set7 and H3K4m1 with the prox-
imal p65 promoter after transient hyperglycemia. (c) Chromatin remodeling 
after transient hyperglycemia as determined by susceptibility to Eag1 
digestion. Nuclei from treated cells were isolated, digested by Eag1, and 
the extracted DNA amplifi  ed by quantitative PCR over the indicated p65 
promoter region. *, P   <   0.05 versus LG group. For each graph,   n   = 3. Error 
bars show SEM.     JEM VOL. 205, September 29, 2008 
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the same extent as they were in WT mice exposed to tran-
sient hyperglycemia. Expression of MCP-1 and VCAM-1 
was also increased (  Fig. 4, c and d  , respectively). Similarly, 
because these hyperglycemia-induced eff  ects were also pre-
vented by overexpression of glyoxalase 1 in vitro, we ana-
lyzed the same variables in aortic endothelial cells isolated 
from nondiabetic glyoxalase 1 knockdown mice. The eff  ects 
on both H3K4m1 at the NF-    B promoter and p65 ex-
pression were qualitatively similar to those observed with 
both transient hyperglycemia and in   UCP-2  +/        mice (  Fig. 4, 
e and f  , respectively). These results demonstrate that increased 
intracellular ROS, which normally are generated by hyper-
glycemia, are suffi   cient to induce both increased H3K4me1 
at the NF-    B promoter and p65 expression in the absence of 
hyperglycemia. Similarly, they show that increased glyoxalase 
1 substrate, which normally occurs as a consequence of 
hyperglycemia (  26  ), is suffi     cient to induce both increased 
H3K4me1 at the NF-    B promoter and p65 expression in 
the absence of hyperglycemia. Thus, the proximate mecha-
nistic events mediating increased p65 expression are HG-
induced ROS and subsequent methylglyoxal formation. 
The distal mechanistic events are chromatin remodeling, Set7 
recruitment, and increased H3K4 monomethylation in the 
p65 promoter. 
    DISCUSSION   
  In the present study, we show that transient exposure of 
aortic endothelial cells to hyperglycemia induces persistent 
and was prevented by overexpression of UCP-1, MnSOD, 
or GLO1. 
  In nondiabetic mice, transient hyperglycemia induces 
increased H3K4me1 at the p65 promoter and increases p65 
gene transcription 
  To validate our in vitro observations in an animal model, we 
examined the eff  ect of transient hyperglycemia on H3K4me1 
and p65 expression in aortic endothelial cells of nondiabetic 
mice (  Fig. 4  ).   Mice were exposed to hyperglycemia (20 mM 
glucose) for 6 h using pancreatic insulin clamps and killed 
immediately and after 2, 4, and 6 d of subsequent euglycemia. 
Aortic endothelial cells were isolated from these mice by laser 
capture microdissection (LCM), and the levels of H3K4me1 
at the NF-    B p65 promoter were determined by carrier 
ChIP (cChIP;   Fig. 4 a  ) (  25  ). Transient hyperglycemia in-
duced an increase in this activating H3K4 methylation, which 
persisted for the subsequent 6 d of exposure to normal levels 
of blood glucose. These epigenetic changes were associated 
with an increase in NF-    B p65 expression that also persisted 
for the subsequent 6 d of exposure to normal levels of blood 
glucose (  Fig. 4 b  ). Because both of these hyperglycemia-in-
duced eff  ects were prevented by overexpression of UCP-2 in 
vitro, we also analyzed aortic endothelial cells isolated from 
nondiabetic   UCP-2  +/        mice, which produce excess intracel-
lular ROS at normal glucose levels. In the absence of hyper-
glycemia, both the level of H3K4me1 at the NF-    B p65 
promoter and the level of p65 expression were increased to 
    Figure 4.         Persistent increases in Set7-mediated histone methylation and p65 gene expression in nondiabetic mice.   (a and b) WT mice were 
exposed to 20 mM glucose for 6 h using a hyperinsulinemic hyperglycemic clamp. Aortas were removed at the indicated times, and aortic endothelial 
cells were isolated by LCM. (a) cChIP of NF-    B p65 promoter by H3K4m1 antibody (  n   = 2). (b) NF-    B p65 subunit mRNA levels (  n   = 3). *, P   <   0.05 versus 
LG. Error bars show SEM. (c and d) Aortic endothelial cells were isolated from   UCP-2  +/      mice by LCM. (c) cChIP of NF-    B p65 promoter by H3K4m1 anti-
body (  n   = 4). (d) p65, MCP-1, and VCAM-1 mRNA levels (  n   = 4). *, P   <   0.05 versus LG. Error bars show SEM. (e and f) Aortic endothelial cells were isolated 
from Glo1 KD mice by LCM. (e) cChIP of NF-    B p65 promoter by H3K4m1 antibody (  n   = 4). (f) p65, MCP-1, and VCAM-1 mRNA levels (  n   = 4). *, P   <   0.05 
versus LG. Error bars show SEM.     2414 TRANSIENT HIGH GLUCOSE CAUSES EPIGENETIC CHANGES   | El-Osta et al. 
  Data from the EDIC study, which followed patients with 
type 1 diabetes after they completed the DCCT, show that 
early chronic exposure to a moderately high level of hyper-
glycemia has prolonged eff  ects on diabetic complications dur-
ing subsequent periods of improved glycemia, a phenomenon 
termed   “  metabolic memory.  ”   For example, atherosclerotic 
changes not even present at the end of the DCCT appeared 
subsequently in the previously higher HbA1c group, followed 
by a twofold increase in myocardial infarction, strokes, and 
cardiovascular death. This occurred despite the fact that their 
HbA1c since the end of the DCCT was identical to that of 
the formerly intensive control group during the entire time 
that these arterial changes developed (  32, 33  ). Whether per-
sistent epigenetic changes induced by transient spikes of hy-
perglycemia play a role in metabolic memory remains to be 
determined by future investigations. 
  In summary, the observations reported here show that 
transient hyperglycemia causes persistent atherogenic eff  ects 
during subsequent normoglycemia by inducing long-lasting 
changes in chromatin remodeling, recruitment of the histone 
methyltransferase Set7, and increased H3K4 monomethyl-
ation in the proximal NF-    B promoter, leading to increased 
expression of p65, MCP-1, and VCAM-1. Together, these 
results provide a molecular basis for understanding some of 
the variation in risk for diabetic complications that is not ex-
plained by HbA1c. 
  MATERIALS AND METHODS 
  Cells and reagents.     Primary HAECs (Cascade Biologics) were maintained 
in medium EGM-2MV bullet kit (Cambrex) supplemented with 10% FBS 
and antibiotics. BAECs were maintained in MEM (Invitrogen) with 0.5% 
FBS and nonessential amino acids (Invitrogen) containing either 5 mM glu-
cose (LG) or 30 mM glucose (HG). The formulation sheets for the media 
used stated that no LPS was present. 
  We also tested for the presence of LPS using the Pyrosate test kit 
(Associates of Cape Cod, Inc.). Antibodies for SET7, LSD1, H3-Ac, H3K9-
Ac, H3K14-Ac, and H3K4me3 were purchased from Millipore. Antibodies 
for H3K4me1 and H3K4me2 were purchased from Abcam. Antibody for 
RNA Pol II was obtained from Santa Cruz Biotechnology, Inc., and anti-
body for unmodifi  ed H3 was obtained from Cell Signaling Technology. 
Antibody to MLL1 was obtained from the laboratory of R.G. Roeder 
(Rockefeller University, New York, NY) and hSET1 antibody was ob-
tained from Bethyl Laboratories, Inc. Non-targeted shRNA and shRNA 
for Set7 lentiviral particles were obtained from Sigma-Aldrich. Negative 
controls for p65 siRNA and p65 siRNA (siRNA ID: 216912) were ob-
tained from Ambion. Adenovirus for UCP1, MnSOD, GLO1 and empty 
vectors were prepared by the Gene Transfer Vector Core (University of 
Iowa, Iowa City, IA). Viruses were infected 24 h preceding treatment with 
HG or LG where stated.   Drosophila melanogaster   SL2 cells were grown at 
26  °  C in Schneider  ’  s medium (Invitrogen). Protein concentrations were 
measured by Coomassie Protein Assay kit (Thermo Fisher Scientifi  c) using 
BSA as a standard. 
  RT reaction and real-time quantitative PCR.     Total RNA from cells 
was extracted using the RNeasy Mini kit or RNeasy Micro kit (QIAGEN), 
and the RNA was reverse transcribed with the SuperScript III First Strand 
Synthesis System (Invitrogen). Real-time quantitative PCR was run on a 
LightCycler 480 with LightCycler 480 SYBR Green I Master kit (Roche). 
PCR was performed by denaturing at 95  °  C for 7 min, followed by 45 cycles 
of denaturation at 95  °  C, annealing at 60  °  C, and extension at 72  °  C for 10 s, 
epigenetic changes in the promoter of the NF-    B p65 sub-
unit in both cultured human aortic endothelial cells and in 
nondiabetic mice. In the proximal promoter region of p65, 
increased monomethylation of histone 3 lysine 4 by the his-
tone methyltransferase Set7 caused a sustained increase in 
p65 gene expression, leading to a sustained increase in ex-
pression of the NF-    B  –  responsive proatherogenic genes MCP-1 
and VCAM-1. These epigenetic changes are caused by in-
creased generation of methylglyoxal because of hyperglycemia-
induced ROS formation by the mitochondrial electron 
transport chain. 
  Our epigenetic fi  ndings are particularly novel for two rea-
sons. First, to our knowledge there are no data about Set7 in-
creasing H3K4 monomethylation modifi  cation of a promoter 
and altering gene expression. It has been commonly assumed, 
based on studies in yeast, that H3K4 methyltransferases func-
tion mainly during elongation after recruitment by elongating 
RNA polymerase complexes (  27  ). Although recent studies in 
animal cells have shown activator-dependent interactions and 
recruitment of other methyltransferases (  28  ), thus indicating 
promoter-related functions that may complement the elonga-
tion-related functions, no studies have implicated Set7 and 
H3K4 monomethylation. Second, and most important clini-
cally, our study is the fi  rst to demonstrate that transient hy-
perglycemia induces chromatin remodeling and vascular 
epigenetic changes that cause persistent increases in proath-
erogenic gene expression during subsequent normoglycemia. 
  Miao et al. (  29  ) reported that nine candidate genes dis-
played increased H3K4Me2 after chronic exposure of the 
human monocytic cell line THP-1 to HG. Three of these 
showed increased gene expression, four showed decreased 
expression, and two showed no diff  erence in gene expression. 
Whether or not these changes persisted during subsequent 
normoglycemia was not investigated. During exposure to 
HG, they found no change in H3K4 dimethyllysine in the 
NF-    B p65 promoter sequence, which is consistent with the 
data reported here (  Fig. 2 c  ). In a separate publication, Miao 
et al. (  8  ) reported that after chronic exposure of the human 
monocytic cell line THP-1 to HG, H3 acetylation at Lys 9 
and Lys 14 was increased at the TNF-     and COX-2 pro-
moters. However, in contrast to our fi  ndings with p65 ex-
pression (Fig. S4), the HDAC inhibitor TSA stimulated 
transcription of these two genes in normal glucose. 
  In addition to posttranslational modifi  cation of histones, 
DNA methylation may also play an epigenetic role in con-
trolling gene expression in adults (  30  ). In a recent study, Ling 
et al. (  31  ) provided a compelling example of how genetic and 
epigenetic factors may interact to confer an age-dependent 
susceptibility to insulin resistance. In muscle from young and 
elderly identical twins, a polymorphism in the promoter of a 
nuclear-encoded electron transport chain protein was associ-
ated with increased DNA methylation in this promoter in the 
older subjects, which correlated with lower levels of gene 
expression and increased insulin resistance. The role of DNA 
methylation in gene expression changes related to metabolic 
memory is a fertile area for future investigation. JEM VOL. 205, September 29, 2008 
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enzyme and incubated for 30 min at 37  °  C. The reaction was stopped by ad-
dition of stop solution containing 50 mM Tris, pH 8, 300 mM NaCl, 25 
mM EDTA, 0.2% SDS, and 0.2 mg/ml Proteinase K. After Proteinase K di-
gestion, genomic DNA was purifi  ed by DNeasy Tissue kit (QIAGEN). 2   μ  l 
DNA samples were used for the analysis of the NF-    B p65 promoter by 
real-time PCR using the forward primer 5    -gtgcagcctcttcgtcctc-3     and reverse 
primer 5    -gtgcactacagacgagccatt-3    . 
  Nondiabetic mouse protocol and sample preparation.     Adult male 
C57B/6 mice were catheterized for pancreatic insulin clamp studies under 
conscious and unrestrained conditions. A primed-continuous infusion of 
3   μ  g/kg/min of somatostatin,     0.3 mU/kg/min of insulin, and 4 ng/kg/
min of glucagon was administered, and a variable infusion of a 25% glucose 
solution was started at time 0 and periodically adjusted to clamp plasma glu-
cose concentration at     5 mM (euglycemic protocol) or at     20 mM (hyper-
glycemic protocol) for 6 h. Groups of mice from each treatment group (for 
each time point,   n   = 3) were killed at days 0, 2, 4, and 6 after the clamping 
procedure. The aortas were isolated and snap frozen in OCT compound. 
10-  μ  m sections were cut by clean microtome and mounted on PEN mem-
brane slides (2.0   μ  m; Leica). 200  –  2,000 aortic endothelial cells per mouse 
were isolated by LCM (Leica) and used for either mRNA preparation or 
cChIP analysis. The animal study protocol was reviewed and approved by 
the Institutional Animal Care and Use Committee of the Albert Einstein 
College of Medicine. 
  UCP-2  +/       and Glo1 knockdown mice.       UCP-2   heterozygous KO mice 
(  UCP-2  +/       ) on a C57/B6 background were kindly provided S. Collins 
(CIIT Centers for Health Research, Research Triangle Park, NC). Glyoxa-
lase 1 knockdown mice on a C57/B6 background were created in the labo-
ratory of M. Brownlee (Albert Einstein College of Medicine, Bronx, NY). 
In brief, short oligonucleotides with a target sequence to mouse Glo1 nt 
235  –  255 in a hairpin sequence with restriction enzyme cohesive end se-
quences were ordered and cloned into the pSilencer 1.0-U6 vector (Am-
bion). Fragments, including the mouse U6 promoter and inserts, were 
subcloned into a lentiviral vector (FUGW; gift from D. Baltimore  ’  s labora-
tory, California Institute of Technology, Pasadena, CA). The recombined 
plasmids were used to generate lentiviral particles. shRNA lentivirus was in-
jected into the perivitelline space of single-cell C57/B6 mouse embryos. Af-
ter incubation of 4  –  6 h, embryos were implanted into pseudopregnant 
females and were carried to term. Mice whose genome contained a single 
copy of the insert were identifi  ed by Southern blotting and used to establish 
founder lines. Glo1 mRNA and protein levels were determined by qPCR 
and WB and further confi  rmed by measurement of glyoxalase activity. Het-
erozygous off  spring of founder #14 had a 45  –  65% decrease in tissue glyoxa-
lase 1 activity, and these mice were used in all experiments. 
  cChIP.     The cChIP was performed using a published method with minor 
modifi  cation (  25  ). In brief, around 2   ×   10  7   SL2 cells were pelleted, mixed 
with     1,000 aorta endothelial cells isolated from mice aorta by LCM, and 
then suspended in 1 ml NB buff  er (15 mM Tris-HCl, pH 7.4, 60 mM KCl, 
15 mM NaCl, 5 mM MgCl  2  , 0.1 mM EGTA, 0.5 mM 2-mercaptoethanol, 
and 0.1 mM PMSF) supplemented with 5 mM sodium butyrate and homog-
enized. Nuclei were released and pelleted at 1,250   g   for 15 min at 4  °  C, re-
suspended in 1 ml NB buff  er plus 0.32 M sucrose, and pelleted at 1,800   g   for 
25 min at 4  °  C. Nuclei were resuspended in 1 ml of digestion buff  er (50 mM 
Tris-HCl, pH 7.4, 0.32 M sucrose, 4 mM MgCl  2 , 1 mM CaCl  2  , and 0.1 mM 
PMSF). 50 U micrococcal nuclease (Sigma-Aldrich) were added and the 
mixture was incubated for 5 min at 28  °  C. The subsequent solution was used 
for ChIP by the indicated antibody after the standard ChIP protocol de-
scribed in the ChIP section of Materials and methods. To account for poten-
tial changes in background during diff  erent stimulation conditions, we 
analyzed     -satellite DNA in cell culture experiments after exposure to tran-
sient hyperglycemia and found that this locus is not aff  ected by the H3K4m1 
modifi  cation. We also have performed ChIP for Set7, and found that there 
is no signifi  cant change in Set7 recruitment to the     -satellite DNA. We also 
respectively. 1   μ  l of each cDNA was used to measure target genes, and the 
results were normalized by     -actin for HAECs and hydroxymethylbilane 
synthase for BAECs. Total RNA from aorta was prepared after homogeniza-
tion in TRIZOL (Invitrogen) with the Ultra-Turrax (IKA). 
  ChIP.     The procedure of ChIP used here was that described by Metivier 
et al. (  34  ) with minor modifi  cation. In brief, treated cells were washed and 
cross-linked using 1% formaldehyde for 20 min. After stopping cross-linking 
by addition of 0.1 M glycine, cell lysates were sonicated and centrifuged. 
500   μ  g of protein was precleared by BSA/salmon sperm DNA and a slurry 
of Protein A Agarose beads. Immunoprecipitations were performed using 
the indicated antibodies or preimmune rabbit IgG in the presence of BSA/
salmon sperm DNA and 50% slurry of Protein A agarose beads. Input and 
immunoprecipitates were washed, eluted, and then incubated for 2 h at 
42  °  C in the presence of Proteinase K followed by 6 h at 65  °  C to reverse the 
formaldehyde cross-linking. DNA fragments were recovered by phenol/
chloroform extraction and ethanol precipitation. A 162-bp fragment for the 
bovine NF-    B p65 promoter and a 161-bp fragment from the human 
NF-    B p65 promoter were amplifi  ed by real-time PCR (quantitative PCR). 
Quantitative PCR values were normalized to input DNA and to the values 
obtained with normal rabbit IgG. The mean fraction of input for 5 mM glu-
cose was arbitrarily set as 100 U, and relative fold changes induced by various 
experimental conditions were calculated from that. 
  Preparation of NF-    B subunit p65 and Set7 knockdown HAECs.   
  HAECs were either transfected by negative control siRNA or siRNA for 
NF-    B subunit p65 using Lipofectamine reagent (Invitrogen). For each ex-
periment, an aliquot of cells were harvested for measurement of mRNA 
level and used if the p65 mRNA was decreased by 80% compared with con-
trol cells. shRNA lentivirus for human Set7 (NM030648) was obtained from 
Sigma-Aldrich. 80% confl  uent HAECs (passage 3) in 96-well plates were in-
fected by     200 MOI of either nontargeted shRNA or Set7 shRNA lentivi-
rus particles in the presence of 8   μ  g/ml polybrene in 0.2 ml of medium. 
Fresh medium containing 10   μ  g/ml puromycin was added after 36 h to se-
lect puromycin-resistant cells. Cells were trypsinized and seeded at a density 
of 100 cells/10-cm dish, and single colonies were picked and characterized. 
Cells that showed at least an 80% decrease in Set7 mRNA levels compared 
with control cells were designated Set7 knockdown-positive cells and used 
for later experiments. 
  H3K4me1-3 ChIP coupled with quantitative PCR-based chromo-
somal walking.     HAECs were treated with LG for 16 h, HG for 16 h, or 
HG for 16 h followed by LG for 6 d. Cells were fi  xed and cross-linked, the 
chromatin was sonicated to achieve 300  –  400-bp DNA fragments, and the 
chromatin was immunoprecipitated by H3K4-me1, me2, and me3 anti-
bodies, respectively. We designed a series of PCR primers so as to produce 
a series of adjacent partially overlapping PCR products ranging in size from 
130 to 170 bp spanning nucleotides +1 to +1500 downstream of the TSS 
and nucleotides     450 to     1 upstream of the TSS. Quantitative PCR and 
data analysis were performed as described in RT reaction and real-time 
quantitative PCR. 
  Eag1 digestion of NF-    B p65 promoter.     Treated HAECs were washed 
with PBS and cross-linked by 1% formaldehyde for 15 min at room temper-
ature. Cells were washed by cold washing solution containing 150 mM su-
crose, 80 mM KCl, 35 mM Hepes, pH 7.4, 5 mM K  2  HPO  4  , 5 mM MgCl  2  , 
and 0.5 mM CaCl  2  , and then permeabilized for 2 min at room temperature 
with ice-cold 0.5 mg/ml lysolecithin (Sigma-Aldrich) dissolved in the cold 
washing solution. Cells were then scraped with a rubber policeman and sus-
pended and homogenized in 700   μ  l of nuclei buff  er containing 25 mM 
Hepes, pH 7.8, 1.5 mM MgCl  2  , 10 mM KCl, 0.1% NP-40, 1 mM DTT, 
and protease inhibitor cocktail (Sigma-Aldrich). Nuclei were then sedi-
mented by 15-min centrifugation at 4  °  C at 1,400   g  . The nuclear pellet was 
then resuspended in 100   μ  l of digestion buff  er (50 mM Tris-HCl, 100 mM 
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that the experimental conditions did not alter levels of either. 
  Statistical analysis.     Results are given as mean   ±   SEM. All experiments 
were performed at least in triplicate, unless otherwise mentioned. Data 
distribution was analyzed, and statistical diff  erences for diff  erent treatments 
were evaluated by the analysis of variance and Tukey-Kramer statistical 
tests using PHStat2 (Pearson Prentice Hall). A P value of   <  0.05 was con-
sidered signifi  cant. 
  Online supplemental material.     Fig. S1 shows the eff  ects of transient HG 
on p65 expression, Set 7 recruitment, and H3K4me1 in BAECs. Fig. S2 dis-
plays the eff  ect of transient HG on total p65 protein level and nuclear p65 
activity in HAECs. Fig. S3 shows the eff  ect of transient HG on Po II associa-
tion with the p65 promoter. Fig. S4 shows the eff  ect of transient HG alone 
on total H3, H3K9, and H3K14 acetylation in the proximal p65 and in the 
presence of TSA. The eff  ects of TSA on recruitment of Set 7, H3K4, and 
expression of p65, MCP-1, and VCAM-1 at physiological glucose concen-
tration are also shown in Fig. S4. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20081188/DC1. 
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